Stockholders' Deficit (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 27, 2022	Mar. 28, 2021
Stockholders' Deficit [Line Items]
Balance	[1]	$ (4,209,536)
Net income		90,964	$ 117,761
Balance		$ (4,198,642)
Common Stock [Member]
Stockholders' Deficit [Line Items]
Balance (in shares)		36,138,273	38,868,350
Balance		$ 361	$ 389
Issuance and cancellation of stock awards, net (in shares)		340	(2,755)
Tax payments for restricted stock upon vesting, (in shares)		(1,875)	(2,791)
Purchases of common stock, (in shares)		(100,810)	(65,870)
Purchases of common stock		$ (1)	$ (1)
Exercises of stock options, (in shares)		1,445	21,263
Balance (in shares)		36,037,373	38,818,197
Balance		$ 360	$ 388
Additional Paid-in Capital [Member]
Stockholders' Deficit [Line Items]
Balance		840	5,122
Tax payments for restricted stock upon vesting		(789)	(1,044)
Purchases of common stock		(4,037)	(6,363)
Exercises of stock options		266	3,693
Non-cash equity-based compensation expense		7,265	5,204
Balance		3,545	6,612
Retained Deficit [Member]
Stockholders' Deficit [Line Items]
Balance		(4,207,917)	(3,303,492)
Net income		90,964	117,761
Dividends declared on common stock and equivalents		(39,765)	(36,475)
Purchases of common stock		(43,623)	(18,636)
Balance		(4,200,341)	(3,240,842)
Accumulated Other Comprehensive Income (Loss) [Member]
Stockholders' Deficit [Line Items]
Balance		(2,820)	(2,424)
Currency translation adjustment		614	186
Balance		$ (2,206)	$ (2,238)

[1] The condensed consolidated balance sheet at January 2, 2022 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.